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Validation of an algorithm to reveal 
the U wave in atrial fibrillation
M. S. Al-Karadi1, A. J. Wilkinson1, J. Caldwell2 & P. Langley  1
Major cardiac organisations recommend U wave abnormalities should be reported during ECG 
interpretation. However, U waves cannot be measured in patients with atrial fibrillation (AF) due to the 
obscuring fibrillatory wave. The aim was to validate a U wave measurement algorithm for AF patients. Multi-
beat averaging was applied to ECGs of 25 patients during paroxysms of AF and the presence of U waves 
compared to those from the same patients during sinus rhythm (SR). In a further database of 10 long-term 
AF recordings, the number of beats for effective U wave extraction by the algorithm was calculated. U waves 
were revealed in all AF recordings and there was no significant difference between the presence of U waves 
in AF and SR (p = 0.88). U wave amplitude was significantly increased in AF (mean (s.d.) amplitude 55 (39) 
AF vs 37 (28) μV SR, p = 0.005). The presence of U waves could easily be discerned when as few as 10 beats 
were used in the algorithm. The study demonstrates the validity of the algorithm to reveal U waves in AF 
recordings. The algorithm offers the potential to detect U wave abnormalities in patients with AF.
The U wave is a small amplitude feature of the ECG occurring at the end of the T wave1,2. It is reported to be pres-
ent in 90% of recordings in healthy subjects1 yet the genesis of the U wave is still in doubt1,3,4. The main hypothe-
ses proposed include, i) delayed ventricular repolarisation of either Purkinje system or mid-myocardial cells and 
ii) stretch induced delayed after depolarisation caused by mechanoelectrical coupling1,3–5. However, none of the 
hypotheses is universally accepted1–3,6.
U wave abnormalities are linked with a range of cardiac diseases, such as ischemia and hypertension, or may 
be due to medications2. Major cardiac organisations such as American Heart Association (AHA) and Heart 
Rhythm Society (HRS) recommended that all U wave abnormalities should be reported during ECG interpreta-
tion2,7. Presently this is not possible for patients with the abnormal heart rhythm AF. Given that AF is associated 
with many cardiac disorders which are also associated with abnormal U waves, for example hypertension, and 
that AF patients are subject to a range of rate and rhythm control medications, it is essential to be able to monitor 
the U wave and detect U wave abnormalities in AF patients.
U waves have rarely been described in patients with AF. This is not surprising because the measurement is dif-
ficult due to the atrial fibrillatory wave obscuring the U wave8. The presence of U waves cannot be discerned in 
AF because the amplitude and morphology of the fibrillatory wave9–11 is similar to that of the U wave. Thus, it is 
important to develop methods which are capable of revealing the U wave in AF so that U wave abnormalities can be 
detected and reported for patients with this arrhythmia. Additionally, the ability to study U waves under the unique 
conditions presented by AF, i.e. the rapid beat interval changes and associated haemodynamic response, will facili-
tate the investigation of U wave mechanisms under such conditions which have never before been studied.
Although the U wave cannot be seen during AF, it is hypothesised that the U wave is present because U waves 
are readily seen in patients with paroxysmal AF during periods of SR. In a preliminary study we demonstrated the 
feasibility of revealing the U wave in AF using an algorithm based on ventricular beat averaging8. Signal averaging 
is a well-known signal processing technique used extensively to reduce noise when multiple repetitions of a small 
amplitude signal are available for measurement12–14. As such it allows small amplitude signal components to be 
measured in the presence of large amplitude noise but only when the signal and noise are uncorrelated12–15. In 
our application ‘signal’ refers to the U wave and ‘noise’ refers to the atrial fibrillatory activity and other unwanted 
components such as power line and electromyogram (EMG) artefact. By careful alignment and summation of 
increasing numbers of ventricular beats the amplitude of the uncorrelated noise is progressively reduced while the 
desired U wave is revealed in the resulting average beat. Theory predicts that the level of noise reduction achieved 
is a function of the number of averaged signal epochs12–14,16, so the quality of the resulting U wave depends on the 
number of beats used to generate the average beat.
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The aims of the present work were two-fold:
 (i) First, to validate the beat averaging algorithm. Our preliminary study8 provided no validation of the U 
wave extraction algorithm, so the first aim was to validate the algorithm. Here we validate the algorithm 
by comparing U waves extracted from AF recordings to U waves readily observable in SR recordings for 
the same patients. This is referred to as the ‘validation study’. Assuming U waves are unchanged during AF, 
validation implies the presence of U waves in both AF and SR recordings.
 (ii) Second, to define the requirements for effective U wave extraction in terms of the number of beats needed 
for beat averaging. Since the quality of the extracted U wave is dependent upon the number of beats used 
to generate the average beat, the second aim was to establish the number of beats required for effective 
U wave extraction in AF recordings. This is referred to as the ‘number of beats study’. It has important 
implications for the clinical application of the algorithm since the number of beats determines the ECG 
recording duration.
Results
Validation study. From the database of 25 patients for which recordings in both AF and SR were available, 
3 patients were excluded because fast heart rates during SR caused the U waves to be obscured by following P 
waves in these patients. After applying the beat averaging algorithm to the recordings of the remaining 22 patients 
all 22 patients had visible U waves in both AF and SR. There were no discrepancies between the reporting of the 
presence of U waves by the two observers. Table 1 provides the contingency table for U waves extracted from AF 
and those in SR. There was no significant difference in the presence of U waves in AF compared to SR (p = 0.88).
Figure 1 shows a representative example of U waves extracted from AF and SR recordings for the same subject. 
Figure 1a illustrates the difficulty of discerning the U wave in AF. It shows a 5 second strip of ECG in which the 
irregular beat intervals and atrial fibrillatory wave obscure the underlying U wave. The U wave was revealed by 
the beat averaging algorithm as shown in Fig. 1b where the U wave extracted from the AF recording is clear and, 
as expected, follows the T wave. Further validation of the algorithm is provided in Fig. 1c,d which show the 5 s 
strip and average beat respectively for the same patient but in SR. The U wave extracted by the algorithm in AF 
was of the same morphology to that in SR but with increased amplitude.
Patients exhibited a wide range of U wave amplitudes. Figure 2 shows the paired relationship between U wave 
amplitudes in SR and AF recordings. The patient with the largest U waves in SR recordings also had the largest U 
waves in AF recordings but the mapping was not consistent across all patients. Interestingly, U wave amplitudes 
during AF were significantly larger than during SR (mean (s.d.) 55 (39) vs 37 (28) μV, p = 0.005) with the majority 
of patients (73% (16/22)) exhibiting larger U waves during AF compared to SR.
Number of beats study. Figure 3 shows the effect on U wave amplitudes by changing the number of beats 
(Nbeats) used to generate the average beat in the U wave extraction algorithm for all recordings. The effect of 
reducing the number of beats from the maximum of 100 beats (reference, Nbeats = 100) was to increase the U wave 
amplitude in all cases. The amplitude increase can be explained by the presence of increasing levels of noise con-
taminating the extracted U wave as the number of beats is reduced. Theory predicts that as the number of beats is 
reduced the effectiveness of noise reduction by beat averaging decreases.
Combining the data for all subjects and analysing the difference of U wave amplitude (ΔU amp) relative to 
the reference U wave amplitude, Fig. 4a shows that there was a mean amplitude difference of 5 μV when using 10 
beats rather than 100 beats to generate the average U wave. In other words, residual noise increased to 5 μV when 
only 10 beats are used in the algorithm compared to 100 beats. Mean amplitude differences were significantly 
greater than zero across the trials (p = 0.0000183, within-subject ANOVA) and post-hoc analysis suggested that 
there were no significant differences in amplitude with respect to reference when at least 70 beats were used 
(mean (s.d.) ΔU amp = 0.2 (0.4) μV, Nbeats = 70 beats, p = 0.1063). When expressed as a percentage of the U wave 
reference amplitude the mean amplitude increase was less than 1% when using 70 or more beats and increased to 
14% when using only 10 beats. Nonetheless, it was observed that with as few as 10 beats (Nbeats = 10) the presence 
of U waves could readily be visually discerned as illustrated in Fig. 4b.
Discussion
This is the first study which validates an algorithm to reveal the U wave in AF patients. In the ‘validation study’ 
U waves were present in all 22 patients during episodes of AF for which U waves could be seen in corresponding 
SR recordings in the same patients. U waves in AF had the same polarity and morphology as those in SR but with 
increased amplitude in most subjects. The increased amplitude in AF could not be accounted for by residual 
noise (i.e. residual atrial fibrillatory wave) since none could be seen in the resulting average beats after close visual 
ECG
Visible U wave
TotalYes No
AF 22 0 22
SR 22 0 22
Total 44 0 44
Table 1. Contingency table of presence of U waves in AF and SR for 22 subjects of the validation study.
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inspection and as illustrated in the example shown in Fig. 1. With the ability to now measure U waves during AF 
the algorithm provides the opportunity for researchers to explore potential mechanisms which might explain 
differences in U waves during AF and SR.
Interestingly, when we applied our algorithm to the AF recordings of the 3 patients which had no observable 
U wave in SR, U waves were present during AF as illustrated in the example of Fig. 5. Although U waves could 
Figure 1. Example to illustrate the presence of U waves in a patient in both AF (top row) and SR (bottom row). 
(a) 5 s strip of ECG in AF in which it is impossible to discern the U waves and (b) the corresponding extracted 
average beat in AF with clear U wave following the T wave. (c) 5 s strip of ECG of the same patient during SR 
demonstrating clear U waves at each beat and d) the corresponding average beat in SR showing a clear U wave 
with the same morphology as those in (b,c).
Figure 2. Comparison of U wave amplitudes measured during SR and AF for the 22 patients in the validation 
study.
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not be seen in the 3 SR recordings it seems likely that U waves were present but simply obscured by the P waves 
of the next cardiac cycle due to the fast heart rates in these SR recordings. Surawicz stated that the U wave cannot 
be seen at fast heart rates1.
Although the mechanism of U wave genesis is unknown, the U wave is a reliable feature unvarying in its 
occurrence at the end of the ventricular cycle in every ventricular beat. The algorithm exploits this feature by 
using the beat averaging technique to reveal the low amplitude U wave12–14. By averaging a number of ventricular 
Figure 3. U wave amplitudes (U amp) for 10 patients in AF, one subplot for each patient. The effect on U wave 
amplitude by decreasing the number of beats (from 100 to 10) used to generate the average beat is illustrated. 
Bars and whiskers indicate mean and standard deviation of amplitude across the 10 sub-trials for Nbeats = {90, 
80, 70, 60, 50, 40, 30, 20, 10}.
www.nature.com/scientificreports/
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beats the overall noise components in the ECG signal are reduced12–14. It is effective because the U wave and noise, 
which includes the atrial fibrillatory wave, are uncorrelated. The noise is effectively ‘averaged out’ over a number 
of ventricular beat cycles.
The number of beats to use in the calculation of the average beats is an important consideration since the 
greater the number of beats the greater the noise reduction. On the other hand, the greater the number of beats, 
the longer duration of recording which is required with associated resource implications. The ‘number of beats 
study’ showed that decreasing the number of beats from 100 to 70 did not significantly affect the U wave ampli-
tude. However, the U wave was readily observable when the average beat was generated from as few as 10 beats 
with an average increase in noise amplitude of only 5 μV or 14% of reference amplitude. The study can be used to 
guide the requirement for the number of beats to use dependent upon the required application.
While in SR recordings the beat averaging algorithm removed some of the noise inherent in all clinical ECG 
recordings, the U wave can be seen without beat averaging in SR with good recording technique. However, at high 
heart rates the U wave becomes obscured by the following P wave1.
The algorithm satisfies an unmet clinical need because until now it has not been possible to report U waves 
in AF. Many studies have noted the diagnostic value of U wave abnormalities, particularly inverted U waves17–19. 
Although we did not detect any abnormal U waves in our cohort the algorithm facilitates the reporting of U wave 
abnormalities in AF patients as recommended by the important cardiac associations2,7. Further, the algorithm 
can be used to provide mechanistic insight into the origin of the U wave since AF is unique in its rapidly changing 
ventricular beat intervals. Preceding RR interval is known to affect ventricular filling dynamics20,21 which are 
implicated in the genesis of the U wave through the electro-mechanical hypothesis of the U wave1,4,5,7,22.
Figure 4. (a) The difference in U wave amplitude (ΔU amp) relative to reference amplitude (Nbeats = 100) for 
reducing numbers of beats (Nbeats = 90…10). Bars and whiskers indicate mean and standard deviation of amplitude 
difference across the 10 patients. (b) Average beats generated from the same AF recording using (i) 100 beats, (ii) 
70 beats and (iii) 10 beats. Increased noise level can be seen in (iii) but the presence of a U wave is readily apparent.
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In conclusion, ventricular beat averaging reveals the U wave in AF patients. The algorithm facilitates the detec-
tion and reporting of U waves and their abnormalities in AF patients.
Methods
ECG databases. Two ECG databases were used in this work according the requirements of the sub-studies 
as described below. The study was approved by the University of Hull and Northumberland Local Research Ethics 
committees and all methods were performed in accordance with the relevant guidelines and regulations.
Validation study. The database comprised recordings from 25 patients for which both AF and SR recordings 
in the same patient were available. Fourteen suitable recordings were available from the PAF Prediction Challenge 
database from PhysioNet23. A further 11 historical recordings from routinely collected ECG during electrophys-
iological studies at Castle Hill Hospital were used. The requirement for individual patient consent was waived 
as the study did not impact clinical care and all data were anonymised. Recording duration for AF or SR was a 
minimum of 4 minutes and recordings had sampling rate of either 128 Hz (PhysioNet) or 1953Hz. The PhysioNet 
recordings comprised two unspecified leads23 whereas the others had standard 12-lead ECG. As the lead with the 
most prominent U wave8 lead V4, or if V4 was not available (i.e. PhysioNet recordings) the lead with the most 
prominent U wave, was analysed.
Number of beats study. The requirement for this database was the availability of long duration AF record-
ings to ensure a large number of ventricular beats to be used in the beat averaging algorithm. For this purpose, 
an existing database of 15 minute, 12-lead ECG recordings from 10 AF patients was used. Patients gave informed 
consent for these recordings. It is the same database used in our preliminary study8. The sampling rate was 500 Hz 
and lead V4 was analysed in this study.
U wave extraction algorithm. AF recordings. U waves were extracted using a beat averaging algorithm. 
The average beat was formed using only beats with similar preceding RR interval. Careful selection of qualifying 
beats with respect to preceding RR interval and their alignment ensured optimum U wave extraction and min-
imised the effects of heart rate dependency of U wave timing and amplitude. The ECG processing workflow is 
illustrated in Fig. 6 and comprises (i) R wave detection, (ii) RR histogram, (iii) selection of qualifying beats and 
(iv) calculation of the average beat and identification of the U wave.
Figure 5. Example to illustrate the presence of U waves in a patient in AF (top row) and the apparent absence 
of U wave in SR (bottom row). (a) 5 s strip of ECG in AF in which it is impossible to discern the U waves and (b) 
the corresponding extracted average beat in AF with clear U wave following the T wave. (c) 5 s strip of ECG of 
the same patient during SR with no visible U waves at each beat and (d) the corresponding average beat in SR 
also showing no U wave. The U wave in SR is likely hidden by the following P wave.
www.nature.com/scientificreports/
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R wave peaks (Ri) were detected automatically and confirmed by visual inspection (Fig. 6a). If present, ectopic 
beats and their adjacent intervals were removed. RR intervals were calculated (RRi−1 = Ri − Ri−1). The RR histo-
gram with bin size (RRbin) of 100 ms was constructed so that the number of beats (Nbeats) at specific RR intervals 
could be identified (Fig. 6b). To ensure the average beat was generated using the maximum number of beats with 
similar RR intervals, only beats falling within the bin with the most number of beats were selected (Fig. 6c). In 
other words, qualifying beats had RRi−1 = RRmode ± 50 ms, where RRmode was the histogram bin with most number 
of beats. A further requirement was to exclude beats with short following RR intervals (RRi) that would otherwise 
contaminate the averaged U wave, therefore beats with RRi less than a threshold (RRmin) of 650 ms were excluded. 
All qualifying beats were aligned to their R wave peak (Ri) (Fig. 6c), and the average beat in each lead was calcu-
lated as the mean amplitude across the beats (Fig. 6d). The presence of a U wave was identified from the average 
beat (Fig. 6d). It is important to note that it is the preceding RR interval (RRi-1) which is important to consider 
rather than the RR interval containing the U wave (RRi) since our preparatory work indicated that the preceding 
RR interval is the major determinant of U wave amplitude.
SR recordings. With good quality SR recordings, the U wave can be readily seen without significant processing. 
However most clinical recordings present some noise and by applying the same beat averaging algorithm as for 
the AF recordings the resulting noise reduction allows for optimal presentation of U waves. Hence SR recordings 
were processed by the same algorithm used for the AF recordings. However, in SR at fast heart rates the P wave 
can impinge on the U wave so it was necessary to extend the RRmin interval to ensure that any following P waves 
would not contaminate the beat averaged U wave.
Data analysis. Validation study. For each patient the presence or absence of U waves in the average beat 
was assessed visually and independently by two observers (MSA, PL). A positive validation outcome was defined 
as the presence of U waves of same polarity and morphology in both SR and AF recordings from the same patient, 
otherwise a negative validation outcome was recorded. Validation outcomes were recorded in a contingency table 
and statistical significance of agreement between U wave presence in AF and SR assessed by McNemar’s test. 
U wave amplitude from baseline to U peak was measured automatically but confirmed visually. Stable baseline 
amplitude was estimated from a 10-sample window in the electrically quiescent period before the onset of the 
QRS complex in AF recordings and before the onset of the P wave in SR recordings. Significance of differences in 
amplitude between SR and AF recordings was assessed by paired t-test.
Number of beats study. To determine the effect of the number of beats (Nbeats) on the quality of extracted U 
waves in AF recordings, the algorithm was systematically iterated with diminishing number of beats used for beat 
averaging at each iteration. Trials were conducted where the number of beats was systematically reduced from 100 
beats (reference) in steps of 10 down to 10 beats (i.e. Nbeats = {100, 90, 80, 70, 60, 50, 40, 30, 20, 10}).
Rather than discard some beats for trials where Nbeats was less than 100, multiple sub-trials were conducted so 
that all 100 beats were analyzed across all the sub-trials. This was achieved by dividing the 100 beats into contigu-
ous groups of 10 beats. For each Nbeats trial, 10 sub-trials were conducted, systematically including the appropriate 
number of groups of 10 beats so that over the 10 trials all the beats were used. See the example in Figure A1 (sup-
plementary document).
Figure 6. Signal processing workflow to extract U waves from AF recordings. R wave peaks ( ) were detected 
in the ECG lead (a) from which the RR histogram (bin size RRbin = 100 ms) was created (b). Beats meeting the 
selection criteria (RRi−1 = RRmode ± 50 ms and RRi > RRmin) were extracted from the ECG lead and aligned to 
the R peak (Ri) (c). The average beat (d) was calculated from the collection of beats over the interval 
corresponding to the grey area in (c) revealing the U wave.
www.nature.com/scientificreports/
8SCiENTiFiC RePoRtS |  (2018) 8:11946  | DOI:10.1038/s41598-018-30493-8
Noise reduction and hence U wave quality was quantified by U wave amplitude since U waves contaminated 
by noise have larger amplitude than clean U waves. Amplitude measurement was as described for the valida-
tion study. Differences between U wave amplitude for each Nbeats trial and reference U wave (Nbeats = 100 beats) 
were calculated as ΔU amp = U amp (Nbeats) − U amp (Nbeats = 100)) and statistical differences with respect to 
zero amplitude difference assessed by within subjects ANOVA and post-hoc t-test. All tests were two-sided and 
p-values less than 0.05 considered statistically significant.
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